Clinical Trials Market Scope And Analysis

  • Report Code : TIPRE00006203
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 211
Buy Now

Clinical Trials Market Trends and Scope by 2031

Buy Now


Clinical Trials Market Report Scope

Report Attribute Details
Market size in 2023 US$ 43.37 Billion
Market Size by 2031 US$ 73.33 Billion
Global CAGR (2023 - 2031) 6.8%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Study Design
  • Interventional Trials
  • Expanded Access Trials
By Indications
  • Autoimmune Diseases/Inflammation
  • Pain Management
  • Oncological Conditions
  • Neurological Disorders
  • Diabetes
  • Obesity
  • Metabolic Disorders
  • Cardiovascular Diseases
By Phase Type
  • Phase I
  • Phase II
  • Phase III
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • IQVIA Holdings Inc
  • Parexel International Corporation
  • IXICO Plc
  • Charles River Laboratories Inc
  • ICON Plc
  • WuXi AppTec Co Ltd
  • SGS SA
  • Syneos Health Inc
  • SIRO Clinpharm Private Limited
  • Thermo Fisher Scientific Inc